• CTS provides methadone to treat opioid addiction under the supervision of a physician. CTS is a SAMSHA certified Opioid Treatment Program (OTP).
  • CTS provides a safe and controlled level of methadone to overcome the use of an abused opioid.
  • Methadone works by eliminating withdrawal symptoms and cravings for illicit drugs. Methadone does not produce euphoria in a person with Opioid Use Disorder.
  • Methadone provided at the proper dose, has no adverse effects on a person’s intelligence, mental capability, physical functioning, or employability.
  • Methadone is administered in a liquid form and taken by the patient at the clinic once a day except Sundays when a take home dose is administered.
  • After a period of stability (based on progress and proven, consistent compliance with the Methadone medication dosage), patients may be allowed to take Methadone at home between visits.
  • CTS offers 6 phases of take-home eligibility ranging from phase 1 (Sunday only) to phase 6 (up to 28 days including Sunday).

Why Medication-Assisted Treatment (MAT)?

With continued drug use, a person’s ability to exert self-control can become seriously impaired.

Brain imaging studies from people addicted to drugs show physical changes in areas of the brain that are critical for judgment, decision-making, learning, memory, and behavior control.

Scientists believe that these changes alter the way the brain works and may help explain the compulsive and destructive behaviors of a person who becomes addicted.


is not a
it is a

Length of Treatment

  • The length of time in methadone treatment varies from person to person.
  • Some patients may require treatment for years. People may safely take medications used in MAT for months, years, several years, or even a lifetime.
  • Even if a patient feels that they are ready to stop methadone treatment, it must be stopped gradually to prevent withdrawal. Such a decision should be supervised by a doctor.

Medication and Counseling Treatment

  • Medication-Assisted Treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies.
  • Counseling is provided through individual sessions, family sessions, or group therapy sessions. The purpose of counseling is to provide a patient with new knowledge, new skills to cope and deal with stressful situations when they arise and provide the means to remain drug-free while achieving a better quality of life.

First Appointment

  • During your first appointment you will meet with a nurse practitioner and counselor to talk about your addiction and discuss if methadone treatment is a good fit for you.
  • A clinical and medical evaluation will be completed.
  • The counselor will tell you about the CTS treatment program and review the program guidelines and some of the goals with you.
  • You are free to ask questions during this appointment and at any time during your treatment.
  • The clinical evaluation will review your drug use history, its effects on your life, the presence of any co-occurring disorders like depression. This time will also involve other tasks such as signing consent forms and obtaining personal data.
  • The medical evaluation reviews your health history, your current general health, and any special medication needs you may have, and verify your readiness to receive methadone medication.
  • A physical exam is also provided.
  • Once the physician signs for you to receive methadone, you will be given your first dose. During your first appointment you will meet with a nurse practitioner and counselor to talk about your addiction and discuss if methadone treatment is a good fit for you.

Pregnant or Breastfeeding Women and Methodone

  • Women who are pregnant or breastfeeding can safely take methadone. When withdrawal from an abused drug happens to a pregnant woman, it causes the uterus to contract and may bring on miscarriage or premature birth. Methadone’s ability to prevent withdrawal symptoms helps pregnant women better manage their addiction while avoiding health risks to both mother and baby. SAMHSA
  • In the United States, methadone remains the current standard of care for the use of MAT with pregnant women who have opioid dependency. SAMSHA